Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 983951, 6 pages
http://dx.doi.org/10.1155/2015/983951
Research Article

Identification of a Potential Target of Capsaicin by Computational Target Fishing

1College of Ecology, Lishui University, Lishui, Zhejiang 323000, China
2Department of Traditional Chinese Medicine, Zhejiang Pharmaceutical College, Ningbo 315100, China

Received 15 September 2015; Revised 17 November 2015; Accepted 18 November 2015

Academic Editor: Ki-Wan Oh

Copyright © 2015 Xuan-yi Ye et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. K. Sharma, A. S. Vij, and M. Sharma, “Mechanisms and clinical uses of capsaicin,” European Journal of Pharmacology, vol. 720, no. 1–3, pp. 55–62, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M. De Lourdes Reyes-Escogido, E. G. Gonzalez-Mondragon, and E. Vazquez-Tzompantzi, “Chemical and pharmacological aspects of capsaicin,” Molecules, vol. 16, no. 2, pp. 1253–1270, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Szolcsányi, “Forty years in capsaicin research for sensory pharmacology and physiology,” Neuropeptides, vol. 38, no. 6, pp. 377–384, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. X.-F. Huang, J.-Y. Xue, A.-Q. Jiang, and H.-L. Zhu, “Capsaicin and its analogues: structure-activity relationship study,” Current Medicinal Chemistry, vol. 20, no. 21, pp. 2661–2672, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Díaz-Laviada and N. Rodríguez-Henche, “The potential antitumor effects of capsaicin,” Progress in Drug Research, vol. 68, pp. 181–208, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Wang and X.-Q. Xie, “Computational target fishing: what should chemogenomics researchers expect for the future of in silico drug design and discovery?” Future Medicinal Chemistry, vol. 6, no. 3, pp. 247–249, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Lomenick, R. W. Olsen, and J. Huang, “Identification of direct protein targets of small molecules,” ACS Chemical Biology, vol. 6, no. 1, pp. 34–46, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Cereto-Massagué, M. J. Ojeda, C. Valls, M. Mulero, G. Pujadas, and S. Garcia-Vallve, “Tools for in silico target fishing,” Methods, vol. 71, pp. 98–103, 2015. View at Publisher · View at Google Scholar
  9. P. S. Kharkar, S. Warrier, and R. S. Gaud, “Reverse docking: a powerful tool for drug repositioning and drug rescue,” Future Medicinal Chemistry, vol. 6, no. 3, pp. 333–342, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. S.-J. Chen and J.-L. Ren, “Identification of a potential anticancer target of Danshensu by inverse docking,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 1, pp. 111–116, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. S.-J. Chen, “A potential target of Tanshinone IIA for acute promyelocytic leukemia revealed by inverse docking and drug repurposing,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 10, pp. 4301–4305, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Liu, S. Ouyang, B. Yu et al., “PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach,” Nucleic Acids Research, vol. 38, no. 2, pp. W609–W614, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. K. N. Chitrala and S. Yeguvapalli, “Computational prediction and analysis of breast cancer targets for 6-methyl-1, 3, 8-trichlorodibenzofuran,” PLoS ONE, vol. 9, no. 11, Article ID e109185, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Yang, K. J. Wang, L. S. Wang et al., “Chemical-protein interactome and its application in off-target identification,” Interdisciplinary Sciences: Computational Life Sciences, vol. 3, no. 1, pp. 22–30, 2011. View at Publisher · View at Google Scholar
  15. H. Luo, J. Chen, L. Shi et al., “DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome,” Nucleic Acids Research, vol. 39, supplement 2, pp. W492–W498, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Luo, P. Zhang, H. Huang et al., “DDI-CPI, a server that predicts drug-drug interactions through implementing the chemical-protein interactome,” Nucleic Acids Research, vol. 42, no. 1, pp. W46–W52, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. O. Trott and A. J. Olson, “AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading,” Journal of Computational Chemistry, vol. 31, no. 2, pp. 455–461, 2010. View at Google Scholar
  18. A. Sridhar, S. Saremy, and B. Bhattacharjee, “Elucidation of molecular targets of bioactive principles of black cumin relevant to its anti-tumour functionality—an Insilico target fishing approach,” Bioinformation, vol. 10, no. 11, pp. 684–688, 2014. View at Publisher · View at Google Scholar
  19. S. Kumar, L. Jena, K. Mohod, S. Daf, and A. K. Varma, “Virtual screening for potential inhibitors of high-risk human papillomavirus 16 E6 protein,” Interdisciplinary Sciences: Computational Life Sciences, vol. 7, no. 2, pp. 136–142, 2015. View at Publisher · View at Google Scholar
  20. M. Rask-Andersen, M. S. Almén, and H. B. Schiöth, “Trends in the exploitation of novel drug targets,” Nature Reviews Drug Discovery, vol. 10, no. 8, pp. 579–590, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. N. Y. Chan, C. Nislow, and A. Emili, “Recent advances and method development for drug target identification,” Trends in Pharmacological Sciences, vol. 31, no. 2, pp. 82–88, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. S. K. Paramashivam, K. Elayaperumal, B. B. Natarajan, M. Ramamoorthy, S. Balasubramanian, and K. Dhiraviam, “In silico pharmacokinetic and molecular docking studies of small molecules derived from Indigofera aspalathoides Vahl targeting receptor tyrosine kinases,” Bioinformation, vol. 11, no. 2, pp. 73–84, 2015. View at Publisher · View at Google Scholar
  23. J. Yang, A. Roy, and Y. Zhang, “BioLiP: a semi-manually curated database for biologically relevant ligand-protein interactions,” Nucleic Acids Research, vol. 41, no. 1, pp. D1096–D1103, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Imtaiyaz Hassan, B. Shajee, A. Waheed, F. Ahmad, and W. S. Sly, “Structure, function and applications of carbonic anhydrase isozymes,” Bioorganic and Medicinal Chemistry, vol. 21, no. 6, pp. 1570–1582, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. P. A. Boriack-Sjodin, S. Zeitlin, H.-H. Chen et al., “Structural analysis of inhibitor binding to human carbonic anhydrase II,” Protein Science, vol. 7, no. 12, pp. 2483–2489, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Arabaci, I. Gulcin, and S. Alwasel, “Capsaicin: a potent inhibitor of carbonic anhydrase isoenzymes,” Molecules, vol. 19, no. 7, pp. 10103–10114, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. C. T. Supuran, “Carbonic anhydrases: novel therapeutic applications for inhibitors and activators,” Nature Reviews Drug Discovery, vol. 7, no. 2, pp. 168–181, 2008. View at Publisher · View at Google Scholar · View at Scopus